BackgroundNutrition plays an important role in prevention and management of cardiovascular diseases (CVD) in early stages. Recent research demonstrated beneficial effects of various nutritional ingredients on vascular health. The aim of the current study was to evaluate the effects of an L-arginine-based multi ingredient product (AbMIP) on vascular function.MethodsTwenty-five male and female subjects, aged between 45 and 65 years with elevated blood pressure and hyperhomocysteinemia were included in this cross-over trial. Subjects were randomly assigned to one of the two sequence groups (AbMIP -placebo or placebo – AbMIP). AbMIP and placebo were taken for 4 weeks, each. Endothelial function under fasting conditions, blood pressure, postprandial endothelial function after consumption of a high fat meal, homocysteine, asymmetric dimethyl arginine (ADMA) and Hba1c were determined.ResultsAbMIP significantly improved fasting endothelial function determined by EndoPAT™ when compared to placebo (p = 0.047). Similarly, homocysteine levels were significantly decreased after verum supplementation when compared to placebo (p < 0.0001). Systolic blood pressure decreased significantly under AbMIP (p = 0.002) and the reduction was more pronounced when compared to placebo. However, due to placebo-effects no significant difference could be found between groups (p = 0.586). The effects on postprandial endothelial function were stronger for AbMIP when compared with placebo but did not reach significance (p = 0.201). No significant effects of AbMIP were observed regarding HbA1c, ADMA and diastolic blood pressure.ConclusionsDue to improvement on endothelial function, decrease of elevated homocysteine levels and excellent tolerability, AbMIP was demonstrated to be a beneficial option for dietary treatment of endothelial dysfunction and hyperhomocysteinemia in early stages of CVD.Trial registrationThe clinical trials.gov identifier is NCT02392767, November 14, 2014.
Zusammenfassung
In der vorliegenden Praxisstudie wurden Wirksamkeit und Vertr?glichkeit des Rhodiola rosea-Wurzelextrakts SHR-5 (Pr?fpr?parat: Rhodiolan? NE) bei Patienten mit Burn-out- und Ersch?pfungssyndrom untersucht. Bei den erfassten Symptomen (Ersch?pfung, depressive Verstimmung, Schlafst?rungen, M?digkeit, Leistungsabfall) zeigte sich ?ber den Beobachtungszeitraum von 8 Wochen ein hochsignifikanter und kontinuierlicher R?ckgang der Beschwerdeintensit?t um bis zu 63?% bei sehr guter Vertr?glichkeit.
Rhodiola rosea: An adaptogen to treatburnout Rhodiola rosea rootextractsare traditionallyused as atonic to enhance physical and mental performance. Newerclinical studieshaveshown that Rhodiola-extractscan be used to treatstress-relatedphysical and mentalexhaustion (burnout), mild depression and general anxiety.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.